written on 03.06.2014
Tags:
,

Ombudsman "not satisfied" with EMA's explanation of disclosure policy changes

TAGS: ,

The battle of wits between the European Medicines Agency and the European Ombudsman over the EMA's clinical trial data disclosure policy has been ratcheted up a couple of notches after the Ombudsman, Emily O'Reilly, rejected the agency's arguments in…

Latest Report